In melanoma patients, peritumoral injection of IFNβ recruits and stimulates immune effector cells, such as cytotoxic T cells, into the tumor microenvironment [23], suggesting a possible mechanism for the therapeutic effect of IFNβ in the treatment of melanoma. This evidence concerns the gene IFNB1 and neoplasm.